Related Experiment Video

Updated: May 13, 2026

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology
09:33

A Methodological Approach to Non-invasive Assessments of Vascular Function and Morphology

Published on: February 7, 2015

Cardio-ankle vascular index in subjects with dyslipidaemia and other cardiovascular risk factors

Vladimir Soska1, Michaela Frantisova, Petr Dobsak

  • 12nd Clinic of Internal Medicine, Masaryk University of Brno, Czech Republic. vladimir.soska@fnusa.cz

Journal of Atherosclerosis and Thrombosis
|March 6, 2013
PubMed

Insights

Cardio-ankle vascular index (CAVI) in dyslipidaemia patients is not affected by hypertension or diabetes. However, CAVI is significantly increased by smoking, indicating its impact on arterial stiffness.

Area of Science:

  • Cardiovascular Medicine
  • Vascular Biology
  • Biomarkers

Background:

  • Arterial stiffness and atherosclerosis are key indicators of cardiovascular risk.
  • The cardio-ankle vascular index (CAVI) is a non-invasive measure reflecting these conditions.
  • Dyslipidaemia (DLP) is a primary risk factor for cardiovascular disease.

Purpose of the Study:

  • To investigate the influence of common cardiovascular risk factors on CAVI in patients with dyslipidaemia.
  • Specifically examine the impact of hypertension, diabetes mellitus, and smoking on CAVI values.

Main Methods:

  • A cohort of 392 dyslipidaemia patients (median age 58.5 years) were analyzed.
  • Cardio-ankle vascular index (CAVI) was measured using the VaSera 1500 system.
  • Statistical analysis assessed correlations between CAVI and age, blood pressure, sex, smoking status, and diabetes.

Main Results:

  • CAVI correlated significantly with age and blood pressure.
  • No significant difference in CAVI was observed between smokers and non-smokers, or between diabetic and non-diabetic subjects.
  • Adjusted CAVI values were significantly higher in smokers compared to non-smokers.

Conclusions:

  • Hypertension and diabetes mellitus do not significantly alter CAVI in dyslipidaemia patients.
  • Smoking is a significant factor that increases CAVI in this patient group.
  • CAVI may serve as a valuable indicator of smoking-induced vascular changes in dyslipidaemia.
Abstract

More Related Videos

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research08:42

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research

Published on: October 22, 2014

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Assessment of the Cardiovascular System III: Palpation01:27

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cardiovascular System Abnormal Findings I: Inspection and Palpation01:29

Cardiovascular System Abnormal Findings I: Inspection and Palpation

In a cardiovascular examination, inspection and palpation are crucial for identifying abnormalities.
Abnormal findings observed during an inspection